SIXERA PHARMA AB has a total of 17 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are AKAAL PHARMA PTY LTD, CATABASIS PHARMACEUTICALS INC and EGIS GYOGYSZERGYAR NYILVANOSAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Serbia | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | Hungary | 1 | |
#9 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Linschoten Marcel | 7 |
#2 | Wagberg Fredrik | 6 |
#3 | Leonardsson Goran | 5 |
#4 | Wågberg Fredrik | 3 |
#5 | Leonardsson Göran | 3 |
#6 | Marcel Linschoten | 1 |
#7 | Leonardsson Goeran | 1 |
Publication | Filing date | Title |
---|---|---|
CA2934024A1 | New kallikrein 7 inhibitors | |
CN106132941A | For treating dermopathic benzoxazine ketone derivatives |